BRITTNEY WHITE: Open Payments
NPI 1801439021 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 22 payments from 13 companies in 2025. Trend: 2023 $207 · 2024 $274 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $145 |
| Novo Nordisk Inc | 4 | $93 |
| Aimmune Therapeutics, Inc. | 1 | $36 |
| Amgen Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $24 |
| Digestive Care, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $19 |
Products named: MOUNJARO, Wegovy, VOWST, Rybelsus, OTEZLA, GIVLAARI, XIFAXAN, Heplisav-B.
Industry payments across VA — which companies pay providers there.
